MARKET

OGEN

OGEN

Oragenics
AMEX
0.2740
+0.0034
+1.26%
After Hours: 0.2982 +0.0242 +8.83% 19:44 11/22 EST
OPEN
0.2706
PREV CLOSE
0.2706
HIGH
0.2880
LOW
0.2602
VOLUME
225.03K
TURNOVER
--
52 WEEK HIGH
7.74
52 WEEK LOW
0.2542
MARKET CAP
3.35M
P/E (TTM)
-0.0421
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OGEN last week (1111-1115)?
Weekly Report · 6d ago
Earnings week ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and more
Seeking Alpha · 6d ago
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 11/12 11:11
Weekly Report: what happened at OGEN last week (1104-1108)?
Weekly Report · 11/11 09:37
Weekly Report: what happened at OGEN last week (1028-1101)?
Weekly Report · 11/04 09:37
Weekly Report: what happened at OGEN last week (1021-1025)?
Weekly Report · 10/28 09:34
Weekly Report: what happened at OGEN last week (1014-1018)?
Weekly Report · 10/21 09:34
Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit
Barchart · 10/18 07:30
More
About OGEN
Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. It is focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for treating Niemann Pick Disease Type C (NPC), and proprietary powder formulation and an intranasal delivery device. Its lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. It is also focused on developing medical products that treat brain related illnesses and diseases (the Neurology Assets). Its lead product and focus is on the development and commercialization of ONP-002 for the treatment of mTBI.

Webull offers Oragenics Inc stock information, including AMEX: OGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OGEN stock methods without spending real money on the virtual paper trading platform.